Electronic Patient-Reported Outcome Data Collection Systems in Oncology Clinical Trials: A Survey of Clinical Research Professionals (an Alliance Study)

被引:0
|
作者
Cho, Youmin [1 ,7 ]
Smith, Ellen M. Lavoie [2 ]
Zahrieh, David [3 ]
Chow, Selina L. [4 ]
Williams, David A. [5 ]
Saint Arnault, Denise [6 ]
Jiang, Yun [6 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX USA
[2] Univ Alabama Birmingham, Sch Nursing, Birmingham, AL USA
[3] Mayo Clin, Alliance Stat & Data Management Ctr, Rochester, MN USA
[4] Univ Chicago, Alliance Protocol Operat Off, Chicago, IL USA
[5] Univ Michigan, Med Sch, Ann Arbor, MI USA
[6] Univ Michigan, Sch Nursing, Ann Arbor, MI USA
[7] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, 7000 FanninSt, Houston, TX 77030 USA
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE To describe clinical research professionals (CRPs)' experiences with electronic patient-reported outcome (ePRO) data collection systems in oncology clinical trials and identify correlates of CRPs' attitude toward technology. METHODS An online survey was conducted among 210 CRPs from 125 National Cancer Institute-funded research sites. Measures included CRPs' demographic characteristics, working years, employment locations, and previous experiences with various types of ePROs. Their attitude toward technology was measured by the Technology Attitude Scale-Adapted. The Wilcoxon signed-rank test was used to compare two subdomains of attitude (perceived usefulness [PU] and perceived ease of use [PEU]). Multiple linear regression was used to explore correlates of (1) overall attitude, (2) PU, and (3) PEU. The significance level was 5%. RESULTS Participants' median age was 41 years (range, 21-67). Most were female (90%) and White (82%). More than half of the participants had previous experiences with web-based ePROs using patients' own devices (72%) or site-/sponsor-provided on-site devices (eg, kiosks or tablets; 64%). CRPs who were 60 years or older (beta = -0.32, P < .05) or worked for 10-20 years (beta = -0.11, P < .05) had relatively negative attitudes, controlling for other factors. Previous experiences with more ePRO types were associated with more positive attitudes (beta = 0.08, P = .02). Similar correlates were found with PU but not with PEU. CONCLUSION This study revealed that CRPs had various experiences with ePRO systems and attitudes toward technology. Age, working years, and previous experiences with ePROs were correlates of overall attitude toward technology and PU. These findings suggest necessary targeted training to facilitate ePRO use in oncology clinical trials by improving CRPs' awareness and attitude toward technology.
引用
下载
收藏
页数:12
相关论文
共 50 条
  • [31] REVIEW OF PATIENT-REPORTED OUTCOMES IN PHASE II ONCOLOGY CLINICAL TRIALS
    Danheiser, S.
    Barkalow, F.
    Finnern, H. W.
    VALUE IN HEALTH, 2010, 13 (07) : A275 - A275
  • [32] An evaluation of the rising significance of patient-reported outcomes in oncology clinical trials
    Deshpande, Vaibhav
    Tilekar, Kalpana
    Pradhan, Gauri
    Kumar, J. B. Senthil
    Narayan, Divya
    Patil, Madhavi
    Shah, Vatsal
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 : S9 - S9
  • [33] REVIEW OF PATIENT-REPORTED OUTCOMES IN PHASE II ONCOLOGY CLINICAL TRIALS
    Finnern, H. W.
    Danheiser, S.
    Barkalow, F.
    ANNALS OF ONCOLOGY, 2010, 21 : 183 - 183
  • [34] Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials
    King-Kallimanis, Bellinda L.
    Calvert, Melanie
    Cella, David
    Cocks, Kim
    Coens, Corneel
    Fairclough, Diane
    Howie, Lynn
    Jonsson, Pall
    Mahendraratnam, Nirosha
    Maues, Julia
    Sarac, Sinan
    Shaw, Jim
    Stigger, Nichelle
    Trask, Peter
    Wieseler, Beate
    VALUE IN HEALTH, 2023, 26 (10) : 1543 - 1548
  • [35] Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials
    Theresa M. Coles
    Adrian F. Hernandez
    Bryce B. Reeve
    Karon Cook
    Michael C. Edwards
    Marc Boutin
    Elizabeth Bush
    Arnold Degboe
    Lothar Roessig
    Amy Rudolph
    Pauline McNulty
    Nikunj Patel
    Trish Kay-Mugford
    Margaret Vernon
    Michael Woloschak
    Gustavo Buchele
    John A. Spertus
    Matthew T. Roe
    Denise Bury
    Kevin Weinfurt
    Health and Quality of Life Outcomes, 19
  • [36] Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials
    Coles, Theresa M.
    Hernandez, Adrian F.
    Reeve, Bryce B.
    Cook, Karon
    Edwards, Michael C.
    Boutin, Marc
    Bush, Elizabeth
    Degboe, Arnold
    Roessig, Lothar
    Rudolph, Amy
    McNulty, Pauline
    Patel, Nikunj
    Kay-Mugford, Trish
    Vernon, Margaret
    Woloschak, Michael
    Buchele, Gustavo
    Spertus, John A.
    Roe, Matthew T.
    Bury, Denise
    Weinfurt, Kevin
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2021, 19 (01)
  • [37] Patient-Reported Outcomes and Clinical Trials
    Althof, Stanley E.
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (07): : 1027 - 1028
  • [38] Considerations when introducing electronic patient-reported outcome data capture in multicentre oncology randomised controlled trials
    Lara Philipps
    Stephanie Foster
    Deborah Gardiner
    Alexa Gillman
    Joanne Haviland
    Elizabeth Hill
    Georgina Manning
    Morgaine Stiles
    Emma Hall
    Rebecca Lewis
    Trials, 23
  • [39] “Bring Your Own Device” (BYOD): The Future of Field-Based Patient-Reported Outcome Data Collection in Clinical Trials?
    Chad Gwaltney
    Stephen Joel Coons
    Paul O’Donohoe
    Hannah O’Gorman
    Matthew Denomey
    Cindy Howry
    Jennifer Ross
    Therapeutic Innovation & Regulatory Science, 2015, 49 : 783 - 791
  • [40] "Bring Your Own Device" (BYOD): The Future of Field-Based Patient-Reported Outcome Data Collection in Clinical Trials?
    Gwaltney, Chad
    Coons, Stephen Joel
    O'Donohoe, Paul
    O'Gorman, Hannah
    Denomey, Matthew
    Howry, Cindy
    Ross, Jennifer
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (06) : 783 - 791